Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis

Cytokine. 1991 May;3(3):266-7. doi: 10.1016/1043-4666(91)90026-a.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / therapy*
  • Biomarkers / blood
  • CD4 Antigens / immunology*
  • Humans
  • Immunoglobulin G / immunology
  • Immunosuppression Therapy* / adverse effects
  • Interferon-gamma / blood*
  • Interleukin-1 / pharmacology
  • Interleukin-2 / blood*
  • Muromonab-CD3
  • Tumor Necrosis Factor-alpha / analysis*

Substances

  • Antibodies, Monoclonal
  • Biomarkers
  • CD4 Antigens
  • Immunoglobulin G
  • Interleukin-1
  • Interleukin-2
  • Muromonab-CD3
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma